Research Articles
A Primer on Valuation: 8 Examples of How Earnings Growth Drives Dividends and Returns
2011-02-13
Valuation Based on Fundamentals In order to prudently answer the question of when to buy a stock, an investor first needs to know the value of the company behind the stock. At the most basic level, a company derives its value based on the fundamentals behind the business it operates. Focusing on, and calculating the […]
A Primer on Valuation: Testing the Wisdom of Ben Graham’s Formula
2011-02-09
If an investor is going to successfully invest in common stocks over their lifetime, there are three important questions that must be correctly answered. What to invest in? When to invest? When to sell? The first question deals with finding the right company or companies that you believe can deliver the returns you are seeking. […]
Ben Graham’s Stock Valuing Formula: It Really Works
2011-02-09
Ben Graham’s famed formula for valuing a stock works in the real world! V* = EPS x (8.5 + 2g) Ten Real World examples of companies growing between zero and 5% These ten examples are based on our article: “A primer on valuation: Testing the Wisdom of Ben Graham’s Formula” (part one) published on 2/08/2011. […]
A Primer on Valuation: Testing the Wisdom of Ben Graham’s Formula
2011-02-09
If an investor is going to successfully invest in common stocks over their lifetime, there are three important questions that must be correctly answered. What to invest in? When to invest? When to sell? The first question deals with finding the right company or companies that you believe can deliver the returns you are seeking. […]
Would Ben Graham Give Warren Buffett an ‘F’ for Holding Coca-Cola?
2011-01-21
As most everyone knows, Warren Buffett received much of his initial investing education from the father of modern security analysis, the venerable Ben Graham. Personally, I attribute most everything I know about investing from reading the teachings of both Graham and Buffett. To me, it only made sense to learn as much as I could […]
6 High Yield Pharmaceutical Companies: Do They Justify the Risk?
2011-01-12
Introduction Today Investors are keenly focused on income while simultaneously very risk averse.This current behavior brings with it a level of frustration.The appetite for yield is high precisely at a time when yields on the traditionally safest investments like bonds and CDs, etc. are at historic lows.On the other hand, dividend yields on many blue-chip […]